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Abstract
Purpose: To assess whether grating-based X-ray dark-field imaging can increase the sensitivity of X-ray projection images in
the diagnosis of pulmonary emphysema and allow for a more accurate assessment of emphysema distribution.
Materials and Methods: Lungs from three mice with pulmonary emphysema and three healthy mice were imaged ex vivo
using a laser-driven compact synchrotron X-ray source. Median signal intensities of transmission (T), dark-field (V) and a
combined parameter (normalized scatter) were compared between emphysema and control group. To determine the
diagnostic value of each parameter in differentiating between healthy and emphysematous lung tissue, a receiver-
operating-characteristic (ROC) curve analysis was performed both on a per-pixel and a per-individual basis. Parametric maps
of emphysema distribution were generated using transmission, dark-field and normalized scatter signal and correlated with
histopathology.
Results: Transmission values relative to water were higher for emphysematous lungs than for control lungs (1.11 vs. 1.06,
p,0.001). There was no difference in median dark-field signal intensities between both groups (0.66 vs. 0.66). Median
normalized scatter was significantly lower in the emphysematous lungs compared to controls (4.9 vs. 10.8, p,0.001), and
was the best parameter for differentiation of healthy vs. emphysematous lung tissue. In a per-pixel analysis, the area under
the ROC curve (AUC) for the normalized scatter value was significantly higher than for transmission (0.86 vs. 0.78, p,0.001)
and dark-field value (0.86 vs. 0.52, p,0.001) alone. Normalized scatter showed very high sensitivity for a wide range of
specificity values (94% sensitivity at 75% specificity). Using the normalized scatter signal to display the regional distribution
of emphysema provides color-coded parametric maps, which show the best correlation with histopathology.
Conclusion: In a murine model, the complementary information provided by X-ray transmission and dark-field images adds
incremental diagnostic value in detecting pulmonary emphysema and visualizing its regional distribution as compared to
conventional X-ray projections.
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Introduction
Chronic obstructive pulmonary disease (COPD) involves
progressive airflow obstruction and airway inflammation [1] and
represents one of the leading causes of morbidity and mortality
throughout the world. [2] Emphysema is a common component of
COPD and is characterized by irreversible destruction of alveolar
architecture with enlargement of distal airspaces. The diagnosis of
pulmonary emphysema as well as its severity assessment largely
relies on pulmonary function tests [3]. Spirometry, however,
strongly depends on patients’ cooperation and cannot assess the
regional distribution of emphysematous changes within the lung.
Conventional chest radiography is commonly used to diagnose the
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presence of emphysema in patients with suspected COPD. Chest
radiograms are highly accurate for advanced emphysema [4] but
only moderately sensitive in patients with mild to moderate
emphysema. [5,6] Furthermore, assessment of emphysema on
chest X-rays shows substantial interobserver disagreement and is
unable to quantify the degree of emphysema. [7] Imaging of
pulmonary emphysema has been greatly improved with high-
resolution computed tomography, however at the cost of exposing
the patient to a higher radiation dose as compared to conventional
chest radiography. [6] Since emphysema is characterized on CT
by abnormally low attenuating lung parenchyma, the presence
and degree of pulmonary emphysema can be assessed visually or
by densitometry. [8,9,10] Although the malignancy risk associated
with the radiation exposure from a single CT examination of an
adult is – if any – very low, the radiation exposure associated with
CT limits its use for frequent follow-up examinations to monitor
disease progression in emphysema.
In addition to an accurate diagnosis, assessing the regional
distribution of pulmonary emphysema can be crucial for clinical
decision-making, e.g., regarding lung volume reduction surgery
and endobronchial procedures. [10,11,12] Conventional chest X-
rays are of limited use in assessing the regional distribution of
emphysema. [10] Using CT densitometry, parametric maps of
emphysema distribution can be generated by identifying voxels in
the lung parenchyma with a CT density below a relative (e.g. 15th
percentile) or absolute (e.g. 2950 Hounsfield units) threshold.
[13,14] This technique shows good reproducibility [15] and has
been validated against pulmonary function tests in clinical trials of
pulmonary emphysema. [16,17] Emphysema distribution can also
be assessed by ventilation/perfusion scintigraphy or SPECT, but
this offers little additional value over CT scanning [10] and is
unable to detect important comorbidities.
Therefore, it would be of great value for emphysema imaging to
develop a radiographic projection technology that is more sensitive
for mild to moderate emphysema than conventional chest
radiography and which would allow for accurate assessment of
emphysema distribution on projection images. Such a technology
can be expected to facilitate early diagnosis of emphysema, and to
frequently obviate the need for CT scanning, thus reducing
radiation exposure.
In grating-based imaging, a grating interferometer is introduced
into an x-ray projection setup and allows to extract three different
contrast modalities [18]: in addition to the transmission signal
(equivalent to a conventional x-ray image), grating based x-ray
imaging generates a phase-contrast signal as well as a dark-field
signal. [18] The phase-contrast signal represents the first derivative
of the phase shift [19] while the dark-field signal measures the local
small angle scattering of x-rays in the object. [18] Theoretical
considerations and experimental data have shown that both phase-
contrast and dark-field signals reveal additional information on the
specimen, complimentary to the information provided by the
transmission signal. [20,21,22] In dark-field imaging, the signal
strength is determined by small-angle scattering from microstruc-
tures on a scale below the spatial resolution of the imaging system
[18,22] thus revealing structural information that is inaccessible
for transmission and phase-contrast images. [20] This makes X-
ray dark-field imaging a promising technology for lung imaging,
since the alveoli that constitute most of the pulmonary parenchy-
ma have a diameter well below the resolution of clinical X-ray
projection images.
A recent study demonstrated that diagnosing and mapping
pulmonary emphysema is feasible by combining transmission and
dark-field signal in grating-based X-ray imaging. [23] Based on
the data from this feasibility study, the purpose of the present study
was to investigate whether grating-based X-ray dark-field imaging
increases the sensitivity of X-ray projection images for pulmonary
emphysema and allows for a more accurate assessment of
emphysema distribution on projection images as compared to
conventional X-ray transmission images alone.
Materials and Methods
Ethics and Animal Welfare
This study does not involve human participants or human
samples. Animal experiments were performed with permission of
the Institutional Animal Care and Use Committee of the district
government of Upper Bavaria. Experiments were performed
according to national (GV-SOLAS) and international (FELASA)
animal welfare guidelines. Mice were kept in fully air-conditioned
and pathogen free conditions and had free access to water and
rodent laboratory chow at all times. To allow for adaptation, mice
were kept in the animal facilities at least 7 days prior to starting the
experiments. Mice were visited daily and euthanized if any signs of
suffering (such as weight loss .10%, food denial, aggressive or
apathetic behavior, heavy breathing, bleeding from mouth or
nose) were observed. To ameliorate suffering, mice were
anesthetized using intraperitoneal injection of Medetomidine,
Midazolam and Fentanyl for both the endotracheal application of
elastase and for pulmonary function tests. Following pulmonary
function tests, painless euthanasia was performed by cervical
dislocation under deep anesthesia.
Murine Model of Pulmonary Emphysema
Six- to eight-week-old pathogen-free female C57BL/6N mice
(Charles River Laboratories, Sulzfeld, Germany) were used
throughout this study. To induce pulmonary emphysema,
pancreatic elastase was dissolved in sterile phosphate-buffered
saline and applied once orotracheally (80 U/kg body weight).
Control mice received 80 ml sterile phosphate-buffered saline. [24]
Successful induction of emphysema was confirmed by in vivo
pulmonary function tests. For pulmonary function tests mice were
anesthetized, tracheostomized and connected to a FlexiVent
pulmonary function system (Scireq, EMKA Technologies, Paris,
France). During the measurement mice were ventilated with an
average breathing frequency of 160/min. A snapshot perturbation
maneuver was applied to determine the overall dynamic
compliance of the respiratory system. Subsequently, forced
oscillation technique perturbation maneuvers were conducted to
measure tissue elastance. For each parameter, an average of three
measurements per mouse was calculated. Mouse lungs were
excised 28 days after elastase application, inflated with air and tied
up at the trachea.
Histopathology. After washing to remove paraformalde-
hyde, lungs were decalcified in 10% EDTA for 5 days.
Subsequently, the specimens were dehydrated and embedded in
paraffin. Multiple 10 mm thin sections were prepared in the
coronal plane at intervals of 0.5 mm to obtain representative
sections covering the entire organ. Sections were deparaffinized,
hydrated, stained using a routine Mayer’s hematoxylin and eosin
(H&E) staining protocol and dehydrated. Sections were scanned at
various magnifications to create digital images.
Imaging setup. The Compact Light Source (CLS) is a
laboratory-scale synchrotron X-ray source, commercially devel-
oped and manufactured by Lyncean Technologies, Inc (Palo Alto,
CA, USA). A radio-frequency electron gun and a laser-driven
photocathode produce single electron bunches, which are
accelerated to an energy level in the range of 20 to 45 MeV in
a linear electron accelerator section. The bunch is stored at this
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energy in a miniature storage ring with a circumference of a few
meters. A high-finesse bow-tie enhancement cavity is located at
one of the straight sections of the storage ring and is resonantly
driven by an infrared laser. At the interaction point the laser and
the electron bunch are tightly focused and pass through each other
on each revolution of the electron bunch and each cycle of the
laser pulse. Through the process of inverse Compton scattering,
pulses of X-rays are produced on each revolution. A grating
Figure 1. Original and segmented transmission and dark-field projection images. On the left, the transmission and dark-field signal from
one original projection image is shown for each control (C1-3) and emphysema (E1-3) mouse. Out of 11 projections acquired for each lung, one
sample projection was chosen visually such as to display both lungs with the least possible overlap (thus resembling a frontal chest radiograph). Lung
tissue areas were isolated from the images using a dark-field signal threshold for segmentation. The threshold was visually determined as the border
of background noise and the signal peak on dark-field signal histograms. This segmentation was used for both dark-field and transmission images,
such that identical lung areas were isolated on both images. The resulting isolated images are shown on the right. Note that this segmentation
approach validly distinguishes pulmonary parenchyma from background signal and also removes most of the trachea and main bronchi.
doi:10.1371/journal.pone.0059526.g001
Figure 2. Signal characteristics of emphysematous and control lungs. The distribution of transmission, dark-field and normalized scatter
values are shown as boxplots for emphysematous and control lungs in a per-pixel (A) and a per-individual (B) analysis. For the per-individual analyses
median values over all 11 projections of each specimen were used (depicted as rhombs). Additionally, the median value over all projections of all
specimens from the respective group is shown (horizontal bar).
doi:10.1371/journal.pone.0059526.g002
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interferometer was placed 16 m from the source. A p/2 phase shift
grating with 5.28 mm pitch (design energy 33 keV) and an
absorption grating with 5.4 mm pitch were used at the first
fractional Talbot distance. The Compact Light Source (CLS) was
operated at an X-ray energy of Epeak = 36 keV.
Image acquisition. Lungs from three mice with pulmonary
emphysema and lungs from three healthy mice were placed in
formalin filled plastic containers and imaged ex vivo in a water bath.
For each sample, 11 projections over 180u were acquired by
rotating the sample around the tomographic axis. Each dataset
consists of a phase-stepping scan of the absorption grating with
respect to the phase grating, over one grating period using 16
steps. The exposure time for each phase step was 5 seconds.
Median radiation exposure per lung was 34 mGy. [25] All images
were recorded using a Varian PaxScan 2520D detector with
square pixels of 127 mm x 127 mm and a CsI scintillator.
Image post-processing. Post-processing was performed
using software written in-house within Matlab. The effect of the
sample on the wavefront was calculated from the raw projections
using Fourier analysis, resulting in three different contrast
modalities: standard absorption, phase-contrast and dark-field
images. Lung tissue areas were isolated from the images using a
dark-field signal threshold for segmentation. The threshold was
visually determined as the border of background noise and the
signal peak on dark-field signal histograms. This segmentation was
used for both dark-field and transmission images, such that
identical lung areas were isolated on both images (see Figure 1).
Data processing and statistical analysis. Data processing
and statistical analysis were performed using Microsoft Excel for
Mac 2011 (version 14.1.3) and IBM SPSS Statistics for Mac
(version 20.0.0.1). Transmission and dark-field signal values
normalized against water were recorded for individual pixels as
well as median values per individual. From the transmission (T)
and dark-field signal (V), we calculated the combined parameter
‘‘normalized scatter’’ defined as S=2 (ln V)/(ln T 2 c). The
correction factor c was necessary, since the transmission values
were normalized against the water bath outside the specimen
container, which does not represent the background of the
specimen. The background of the specimen is formed by the
formalin within the specimen containers. The transmission signal
of the formalin background is slightly higher than the transmission
signal of the surrounding water bath, since the x-ray beam passes
the plastic container. To correct for this, for each specimen, ROIs
were placed in the formalin background inside the containers and
in the water bath surrounding the containers. Their values were
averaged and the correction factor c was calculated as ln
(TFormalin/TWater). The numerical value of c was 0.02. The
Table 1. Cut-off values with maximized AUC in the per-pixel
analysis.
Cut-off AUC
Transmission 1.087 0.50
Dark-field 0.715 0.27
Normalized scatter 7.00 0.73
doi:10.1371/journal.pone.0059526.t001
Figure 3. ROC Analysis. Receiver-operator-characteristic (ROC) curves are shown both in a per-pixel (A) and a per-individual (B) analysis. For the
per-individual analyses median values over all 11 projections of each specimen were used. The corresponding areas under the curve (AUCs) are listed
below.
doi:10.1371/journal.pone.0059526.g003
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resulting parameter S=2 (ln V)/(ln T2 c) can be regarded as the
‘‘normalized scatter’’ of tissue, i. e. the tissue’s scatter normalized
against its transmission. Since both transmission and dark-field
signal are logarithmically related to sample thickness, the
combined parameter normalized scatter is independent of sample
thickness. [23].
Median signal intensities were compared between emphysema
and control group using the Mann-Whitney-U-test. To determine
the diagnostic value of transmission, dark-field and normalized
scatter values in differentiating between healthy and emphysema-
tous lung tissue, a receiver-operating-characteristic (ROC) curve
analysis was performed both on a per-pixel and a per-individual
basis. Corresponding area under the ROC curves (AUC) were
compared using the standard error of the test statistics as derived
from the asymptotic variance covariance. [26] In the pixel-based
analysis, ‘‘optimal’’ cut-off values for transmission, dark-field and
normalized scatter values were determined such as to maximize
the respective area under the curve (AUC). To generate
parametric maps of emphysema distribution, the difference
between pixel values of transmission, dark-field and normalized
scatter from the respective ‘‘optimal’’ cutoff value was calculated
for each pixel and normalized against the interquartile range of
this parameter in the control lungs. The resulting values were
color-coded on a scale ranging from 0–1 interquartile ranges. Only
deviations towards the ‘‘emphysematous’’ signal characteristic
were color-coded such as to identify diseased tissue. The resulting
color-coded parametric maps were superimposed onto the
transmission images depicted in gray scale and compared to
histopathology.
Results
Confirmation of Emphysema by in vivo Pulmonary
Function Tests and Histopathology
Mice in the emphysema group showed increased pulmonary
dynamic compliance (median 72.2 vs. 49.8 mL/cm H2O) and
decreased tissue elastance (median 9.8 vs. 19.9 cm H2O/cm).
Histopathology showed diffuse enlargement of the distal airways.
This confirmed successful induction of emphysema with a
phenotype resembling pulmonary emphysema in humans.
Difference in Transmission, Dark-field and Normalized
Scatter Values between Emphysematous and Healthy
Lungs
In order to evaluate if transmission, dark-field and normalized
scatter can identify emphysematous lung tissue, we compared their
median signal values between projections from healthy and
diseased samples. Normalized scatter was defined as the scatter
signal in a given pixel normalized against its transmission signal as
described in the Methods section. In a per-pixel analysis, median
transmission values relative to water were higher for emphysema-
tous lungs than for control lungs (1.11 vs. 1.06, interquartile range
1.07–1.17 vs. 1.04–1.10, p,0.001, Figure 2A). There was no
difference in median dark-field signal intensities relative to water
between both groups (0.66 vs. 0.66, interquartile range 0.52–0.81
vs. 0.48–0.85, Figure 2A). Median normalized scatter was
significantly lower in the emphysematous lungs compared to
controls (4.9 vs. 10.8, interquartile range 4.1–5.8 vs. 7.5–14.7),
p,0.001, Figure 2A). Similar results were obtained in a per-
individual analysis (Figure 2B). This data suggests that while both
transmission and normalized scatter, but not dark-field signal,
differ between healthy and affected samples, the normalized
scatter value allows the clearest differentiation between the two.
Diagnostic Value of Transmission, Dark-field and
Normalized Scatter Values for the Detection of
Pulmonary Emphysema
To compare the diagnostic value of transmission, dark-field and
normalized scatter, a receiver-operating-characteristic (ROC)
curve analysis was performed both on a per-pixel and a per-
individual basis. In a per-pixel ROC analysis for the detection of
emphysema, the AUC for the normalized scatter value was
significantly higher than for transmission (0.86 vs. 0.78, p,0.001)
and dark-field value (0.86 vs. 0.52, p,0.001) alone (Figure 3A).
Cut-off values maximizing the AUC for all three signals and their
corresponding AUCs are shown in table 1. Again, similar results
were obtained in a per-individual analysis (Figure 3B). Interest-
ingly, transmission and normalized scatter ROC curves show very
distinct characteristics in the per-pixel analysis (Figure 3A).
Normalized scatter showed an extremely high sensitivity for a
wide range of specificity values. For example, for a specificity of
75%, the sensitivity of normalized scatter was 94% compared to a
sensitivity of 67% for transmission. Reversely, transmission
showed higher specificity for emphysematous lung tissue at low
sensitivity values. At 25% sensitivity, specificity for normalized
scatter was 90% compared to 98% for transmission.
Diagnostic Value of Transmission, Dark-field and
Normalized Scatter Values for Assessing the Regional
Distribution of Pulmonary Emphysema in Correlation to
Histopathology
Histopathology showed marked emphysema distributed homo-
geneously throughout all three lungs in the emphysema group and
preserved healthy lung architecture in all lungs in the control
group (Figure 4). To determine if this disease distribution can be
accurately predicted based on our imaging data, we generated
parametric maps of emphysema distribution based on the
deviation of each pixel values from their respective ‘‘optimal’’
cutoff value (determined in the ROC analysis to maximize AUC).
When using transmission values to depict the regional distribution
of emphysema, there are obvious differences between healthy and
emphysematous lung tissue. However, since the thicker central
portions of the lung will inevitably result in higher transmission
than thinner peripheral portions, central regions of control lungs
C1 and C3 were erroneously displayed as diseased while large
peripheral portions of all emphysematous lungs are erroneously
displayed as healthy (Figure 4). Using the dark-field signal alone
was clearly inappropriate to depict the regional distribution of
emphysema. Instead, the peripheral portions of all lungs are
identified as diseased (Figure 4). Using the normalized scatter
Figure 4. Parametric maps of emphysema distribution. To generate parametric maps of emphysema distribution, the difference between pixel
values of transmission (left column), dark-field (second column from left) and normalized scatter (third column from left) from the respective
‘‘optimal’’ cutoff value (determined in the ROC analysis to maximize AUC) was calculated for each pixel and normalized against the interquartile range
of this parameter in the control lungs. The resulting values were color-coded on a scale ranging from 0–1 interquartile ranges. Only deviations
towards the ‘‘emphysematous’’ signal characteristic were color-coded such as to identify diseased tissue. The resulting color-coded parametric maps
were superimposed onto the transmission images depicted in gray scale. Histopathologic images obtained by Mayer’s hematoxylin and eosin (H&E)
staining of the corresponding specimen are shown (right column).
doi:10.1371/journal.pone.0059526.g004
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signal to display the regional distribution of emphysema yields
color-coded parametric maps, which clearly show the best
correlation with histopathology. All three emphysematous lungs
can be recognized as being homogeneously diseased. In the
control lungs, only the large airways and a minimal rim of
peripheral lung tissue are falsely displayed as emphysematous
(Figure 4).
Discussion
A recent proof-of-concept study has demonstrated that it is
feasible to differentiate emphysematous from healthy lung tissue
by combining transmission and dark-field signals from grating-
based X-ray projection images. [23] Based on this data, we show
in this manuscript that this approach is superior to X-ray
transmission images alone in the diagnosis of pulmonary
emphysema and in assessing its regional distribution. Specifically,
we demonstrate in the ROC analysis for detecting emphysema
that the AUC of normalized scatter (which we defined as local
scatter normalized against transmission relative to water) is
significantly higher than the AUC of transmission or dark-field
signal alone. We further showed that the normalized scatter can be
used to generate color-coded parametric maps of emphysema
distribution that show a better correlation with histopathology
than can be achieved using transmission or dark-field signal alone.
We found that the ROC curves of normalized scatter and
transmission show a distinct pattern in the per-pixel analysis.
Normalized scatter shows an extremely high sensitivity for
pulmonary emphysema at intermediate specificity.
On cross-sectional CT images, the quantitative assessment of
transmission values for each voxel known as densitometry allows
valid assessment of emphysema distribution. [10] Densitometric
mapping of pulmonary emphysema is not feasible on radiographic
projection images, since the transmission value of each pixel will
not only reflect parenchymal density but largely depend on the
local thickness of lung parenchyma. This is reflected in the partly
inadequate maps of emphysema distribution that our data
generates based on transmission values alone. Defining normalized
scatter as the projected small angle scattering normalized against
transmission renders this parameter largely independent of sample
thickness thus allowing valid mapping of emphysema on
projection images.
The results of this study have to be seen in the context of the
study design. The X-ray source used in this study was a laser-
driven compact X-ray source also referred to as a laboratory-scale
synchrotron. This X-ray source produces a beam with many of the
characteristics of synchrotron radiation, such as near-monochro-
maticity. In contrast to synchrotron facilities which can be up to
several 100 m in diameter, the Compact Light Source used in this
study measures about 562 m. Current routine medical imaging, in
contrast, uses conventional X-ray sources with polychromatic
spectra. Unlike analyzer-based and standard interferometric
methods, grating-based X-ray imaging has relatively low require-
ments on spatial or temporal coherence and can therefore be
readily performed with conventional X-ray sources. [19,27] This
has been demonstrated in phantom models [21], animal [28] and
human [29] tissue samples. Nevertheless, future studies are needed
to confirm our data regarding the diagnostic value of grating based
X-ray imaging for pulmonary emphysema using a conventional X-
ray source.
Our study was performed using ex vivo mouse lungs. For future
applications of grating-based X-ray lung imaging, overlying
structures of the thorax, particularly ribs and fur, as well as
breathing artifacts may confound both transmission and dark-field
signals. These challenges have to be addressed in subsequent
studies. In order to avoid breathing artifacts, the exposure time of
5 s used in this study appears short enough to stop ventilation in
anesthetized and mechanically ventilated rodents.
The median radiation dose of our setup was 34 mGy. [25] This
is considerably higher than the radiation dose associated with a
standard clinical chest x-ray. [30] However, as demonstrated
previously, reducing the number of phase steps and the spatial
resolution can reduce this dose to approximately 2 mGy without
significant information loss. [25] Also, the setup used in this study
is not designed for in vivo experiments and has therefore not been
optimized for dose efficiency. Technical optimization of the setup
is likely to result in further decreases in radiation dose approaching
that of a conventional radiograph.
CT and CT densitometry are the current clinical standard for
diagnosing and assessing the regional distribution of pulmonary
emphysema. The novel aspect of our study is the incremental
value for combined transmission and dark-field imaging for plain
radiographs. Our study did not compare this approach to CT or
CT densitometry. Grating-based imaging allows to acquire not
only plain radiographs but also tomographies which can again be
reconstructed as transmission and dark-field images. Future studies
are needed to assess whether there is also an incremental value for
combined transmission and dark-field CT over conventional
transmission CT alone.
It is known that the results of CT lung densitometry are
influenced by lung volume, which is why densitometric results
should be corrected for lung volume. [31] Since we did not
perform measurements at different lung volumes, we cannot assess
whether the normalized scatter (dark-field signal normalized over
transmission signal) is also influenced by lung volume. This issue
needs to be addressed in subsequent studies.
Conclusions
Grating-based X-ray imaging allows the acquisition of projec-
tion images from which both transmission and dark-field signals
can be extracted. The complementary information provided by X-
ray transmission and dark-field images adds incremental diagnos-
tic value in detecting pulmonary emphysema and visualizing its
regional distribution as compared to conventional X-ray projec-
tions. In the future, this may allow to detect human pulmonary
emphysema more accurately on chest X-rays and assess its
regional distribution without the use of CT.
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